Final Dividend 2006 Royal DSM N.V.

The DSM Annual General Meeting of Shareholders on 28 March 2007 passed a resolution to declare a dividend for 2006 of EUR 1.00 per ordinary share of EUR 1.50 par value. An interim dividend of EUR 0.33 per ordinary share having been paid on 11 August 2006, the final dividend for 2006 will amount to EUR 0.67 per ordinary share.

This final dividend will be payable to shareholders on the number of ordinary DSM shares held by them on 29 March 2007 at close of business. This final dividend of EUR 0.67 will be paid out entirely in cash, after deduction of 15% dividend tax, and will be made payable from 27 April 2007. The ex-dividend date on Eurolist by Euronext Amsterdam will be 30 March 2007. The record date is 3 April 2007.

Holders of registered shares listed in the register of shares kept by ANT will be informed by ANT about the payment to which they are entitled.

Holders of bearer shares held in a securities account will receive the final dividend through their bank or broker in whose custody the shares are held on 29 March 2007. The dividend will be made payable to them through the intermediary of ABN AMRO Bank N.V. in Amsterdam (Netherlands).

ABN AMRO Bank N.V. is offering all DSM shareholders the option to participate in the dividend reinvestment plan (DRIP).

For further information on the programme see the Investors website at www.dsm.com .

DSM

DSM is active worldwide in nutritional and pharma ingredients, performance materials and industrial chemicals. The company develops, produces and sells innovative products and services that help improve the quality of life. DSM's products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics (E&E). DSM's strategy, named Vision 2010 - Building on Strengths, focuses on accelerating profitable and innovative growth of the company's specialties portfolio. The key drivers of this strategy are market-driven growth and innovation plus an increased presence in emerging economies. The group has annual sales of over EUR 8 billion and employs some 22,000 people worldwide. DSM ranks among the global leaders in many of its fields. The company is headquartered in the Netherlands, with locations in Europe, Asia, Africa, Australia and the Americas. More information about DSM can be found at www.dsm.com .

For more information: DSM Corporate Communications Elvira Luykx tel. 31 (0) 45 5782035 fax 31 (0) 45 5740680 e-mail Email Contact DSM Investor Relations Dries Ausems tel. 31 (0) 45 5782864 fax 31 (0) 45 5782595 e-mail Email Contact